InVivoMAb anti-mouse CD19
BE0150
ApplicationsFlow Cytometry, Neutralisation/Blocking, Other Application
Product group Antibodies
Overview
- SupplierBio X Cell
- Product NameInVivoMAb anti-mouse CD19
- Delivery Days Customer7
- ApplicationsFlow Cytometry, Neutralisation/Blocking, Other Application
- CertificationResearch Use Only
- ClonalityMonoclonal
- Clone ID1D3
- Concentration4-11 mg/ml
- Estimated Purity>95%
- HostRat
- IsotypeIgG2a
- Storage Instruction2°C to 8°C
- UNSPSC12352203
References
- Säwén P, Lang S, Mandal P, et al. Mitotic History Reveals Distinct Stem Cell Populations and Their Contributions to Hematopoiesis. Cell Rep. 2016,14(12):2809-18. doi: 10.1016/j.celrep.2016.02.073Read this paper
- Bouffi C, Kartashov AV, Schollaert KL, et al. Transcription Factor Repertoire of Homeostatic Eosinophilopoiesis. J Immunol. 2015,195(6):2683-95. doi: 10.4049/jimmunol.1500510Read this paper
- Carmi Y, Spitzer MH, Linde IL, et al. Allogeneic IgG combined with dendritic cell stimuli induce antitumour T-cell immunity. Nature. 2015,521(7550):99-104. doi: 10.1038/nature14424Read this paper
- Liu B, Lee JB, Chen CY, et al. Collaborative interactions between type 2 innate lymphoid cells and antigen-specific CD4+ Th2 cells exacerbate murine allergic airway diseases with prominent eosinophilia. J Immunol. 2015,194(8):3583-93. doi: 10.4049/jimmunol.1400951Read this paper
- Becker AM, Walcheck B, Bhattacharya D. ADAM17 limits the expression of CSF1R on murine hematopoietic progenitors. Exp Hematol. 2015,43(1):44-52.e1-3. doi: 10.1016/j.exphem.2014.10.001Read this paper
- Dai M, Yip YY, Hellstrom I, et al. Curing mice with large tumors by locally delivering combinations of immunomodulatory antibodies. Clin Cancer Res. 2015,21(5):1127-38. doi: 10.1158/1078-0432.CCR-14-1339Read this paper
- De Obaldia ME, Bell JJ, Wang X, et al. T cell development requires constraint of the myeloid regulator C/EBP-α by the Notch target and transcriptional repressor Hes1. Nat Immunol. 2013,14(12):1277-84. doi: 10.1038/ni.2760Read this paper
- Guo Z, Cheng D, Xia Z, et al. Combined TIM-3 blockade and CD137 activation affords the long-term protection in a murine model of ovarian cancer. J Transl Med. 2013,11:215. doi: 10.1186/1479-5876-11-215Read this paper
- Dai M, Wei H, Yip YY, et al. Long-lasting complete regression of established mouse tumors by counteracting Th2 inflammation. J Immunother. 2013,36(4):248-57. doi: 10.1097/CJI.0b013e3182943549Read this paper
- Purtha WE, Swiecki M, Colonna M, et al. Spontaneous mutation of the Dock2 gene in Irf5-/- mice complicates interpretation of type I interferon production and antibody responses. Proc Natl Acad Sci U S A. 2012,109(15):E898-904. doi: 10.1073/pnas.1118155109Read this paper
